by Ryu Hyunseok
Published 26 Sep.2025 15:02(KST)
Brand Refactoring, the largest shareholder of Kosdaq-listed Dong Sung Pharmaceutical, stated on September 26 that recent media reports alleging “market manipulation” are completely distorted claims that do not reflect the facts. The company plans to respond strongly, including taking legal action, against defamation and the dissemination of false information.
Brand Refactoring explained that the transaction in question was a legitimate personal investment arranged by former Clinomics executive Kim. The two investors involved are actually married. They voluntarily purchased Celestera shares, trusting in the company’s growth potential and the CEO’s management vision.
The total investment amounted to approximately 500 million won, resulting in the purchase of around 1 billion won worth of shares. The company emphasized that this is a normal and legal act of personal investment and is unrelated to any artificial stock price manipulation or illegal activity.
Nevertheless, some reports continue to frame this matter as “market manipulation.”
A company representative stated, “Currently, Dong Sung Pharmaceutical CEO Na Wonkyun is under investigation after being accused of embezzlement and breach of trust at the Seoul Northern District Prosecutors’ Office and the Seoul Metropolitan Police Agency,” adding, “Spreading unverified articles with malicious intent to defend management rights only serves to confuse shareholders.”
The representative further emphasized, “Distorting legitimate investment activities by investors and framing them as market manipulation is a clear case of spreading false information. Brand Refactoring will not only request corrections for all false reports that damage the reputation of the company and its CEO, but will also respond strongly, including pursuing both criminal and civil legal action.”
Brand Refactoring stated that it will continue to prioritize transparent management and the protection of minority shareholders. The company remains committed to proceeding steadily with its rehabilitation process and new business initiatives.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.